Institutional investors purchased a net $5.7 million shares of NVO during the quarter ended March 2017 and now own 8.24% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 5.6 Million shares of Novo Nordisk
RENAISSANCE TECHNOLOGIES LLC Bought 2.5 Million shares of Novo Nordisk
MILLENNIUM MANAGEMENT LLC Bought 1.9 Million shares of Novo Nordisk